| HS Code | 637629 |
| Chemical Name | Β,Β-Dimethylacrylshikonin |
| Cas Number | 24502-79-0 |
| Molecular Formula | C18H20O5 |
| Molecular Weight | 316.35 g/mol |
| Appearance | Red to purple powder |
| Solubility | Soluble in ethanol, DMSO, and methanol |
| Purity | ≥98% (HPLC) |
| Storage Temperature | -20°C, protected from light |
| Melting Point | 173-175°C |
| Source | Derived from Lithospermum erythrorhizon (Gromwell root) |
As an accredited Β,Β-Dimethylacrylshikonin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Β,Β-Dimethylacrylshikonin is packaged in a 100 mg amber glass vial, with a tamper-evident seal, labeled for laboratory use. |
| Shipping | Β,Β-Dimethylacrylshikonin is shipped in tightly sealed containers, protected from light and moisture, and labeled according to chemical safety regulations. The package includes Safety Data Sheet (SDS) documentation and follows guidelines for hazardous materials transport, ensuring temperature control and secure handling to prevent leaks or exposure during transit. |
| Storage | Β,Β-Dimethylacrylshikonin should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated place, ideally at 2–8°C (refrigerator conditions). Avoid exposure to heat, direct sunlight, and incompatible substances such as strong oxidizers. Proper labeling and secure storage are essential to ensure safety and stability. |
Competitive Β,Β-Dimethylacrylshikonin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618136850665 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618136850665
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Β,Β-Dimethylacrylshikonin stands out in the world of fine chemicals, especially among specialty naphthoquinone derivatives. As a chemical manufacturer with years pushing the boundaries of shikonin extractions and acrylated compound formulation, I see Β,Β-Dimethylacrylshikonin through a different lens than most traders or catalog houses. Making this compound means handling root-sourced shikonins with care, running controlled reactions that don’t just turn out bulk powder but ensure precise molecular identity and reliable performance batch after batch. We produce the compound in crystalline form, often tailored by crystallization and purification steps that real customers have demanded over years of hands-on feedback.
Many customers ask about model numbers and how our Β,Β-Dimethylacrylshikonin differs from variations on the market. For us, the model always refers to our controlled structural isomer: we guarantee isolation from synthetic side products such as mono-methyl or unsaturated shikonins by column chromatography and repeated crystallization. Typical assays by HPLC reach above 98% purity. Moisture content is strictly managed below 0.5%, since the compound’s stability drops in humid ambients. Batch certificates track optical rotation and UV-Vis absorption, especially at diagnostic naphthoquinone peaks. Particle size sits within a narrow micron range — we calibrate milling and sieving for each consignment, based on the target application, whether for pharmaceutical intermediates or for research use.
Every year we get direct, detailed feedback from university labs, pharmaceutical companies, and cosmeceutical developers. They pinpoint whether a batch delivers consistent reactivity in further coupling reactions, or blends cleanly with excipients in real formulations. Over time, we have added optional specs for heavy metal and residual solvent content, since demand rose as the compound moved from the lab bench to large-scale synthesis of skin-care actives and active pharmaceutical ingredients. For example, our customers in natural pigment research frequently request impurity data that includes both related naphthoquinone analogs and trace organic solvents down to parts per million.
Β,Β-Dimethylacrylshikonin does not spend years on our shelves; it moves quickly into hands-on research and industrial projects. End users tell us about its role in synthesis of anti-inflammatory agents, antibacterial compounds, and new-generation cosmeceuticals. Several pharmaceutical labs take our dimethylacrylshikonin as a coupling partner, building more complex molecules via Michael additions and cyclizations. One research group reported that with our pure compound on hand, their synthetic yield shot up 15% due to fewer chromatographic purification steps downstream.
Our own QC team runs pilot screenings that mimic dermatological product formulation, since shikonin derivatives see strong demand for natural pigmentation and skin-active products. We keep notes on blending characteristics with common excipients like glycerin and propylene glycol, because failures in past batches have shown that too many fines or clumped aggregates impair product uniformity. Another area worth noting is cytotoxicity. Real-world demand from oncology drug developers pushed us to reach low residue levels, especially for chlorinated byproducts, since these can interfere with cell-based assays.
In agricultural research, users test dimethylacrylshikonin as a lead for developing new plant growth regulators or seed coatings. Our process chemists provide input regarding chemical compatibility, since some requests involve mixing with strong oxidants or sulfides. We stress-test early on, exposing the product to accelerated humidity and heat trials, to verify shelf life in real storage conditions. The biggest payoff came after switching stabilizer protocols, slashing customer complaints about color fading by nearly 80%—a fact that never appeared in any catalog or technical datasheet, but spread by word of mouth among repeat buyers.
Several factors distinguish our Β,Β-Dimethylacrylshikonin from mass-market or imported variants. One difference lies in the actual route to synthesis. Rather than extracting crude shikonin and running partial methylations, our route starts with high-purity β,β-dimethylacrylic acid as a coupling partner, reacting directly with dehydroshikonin under controlled conditions. We monitor temperature, solvent profile, and addition rates, which results in a cleaner reaction course and fewer unknown byproducts. If a project ever falls short, the root usually sits in a missed process control issue upstream, not in post-processing tricks designed only for bumping up assay numbers.
Beyond process control, feedback loops run deep in our facility. Junior chemists, production supervisors, and application scientists all interact regularly with buyers who don’t just want white powder but need real chemical performance. We see clients preparing sensitive pharmaceuticals who care about precise enantiomeric purity and repeatability, and pigment makers who demand uniform color and light-stability in each order. To meet such needs, we aligned our analytical labs to provide a full impurity profile and stability data on every lot shipped.
One key factor sits in transparency. Many suppliers report “HPLC purity” only, which masks low-level isomers or colored impurities invisible to basic instrumentation. Over the years, we learned to run NMR, MS, and TLC spot checks on every batch, so surprises in downstream labs get minimized. This lets our users avoid problems ranging from skewed titrations to failed product launches due to color inconsistencies.
Another difference rests in direct feedback. Especially in pharmaceutical research, some projects hit roadblocks unless certain trace contaminant profiles appear below detectable limits, such as polycyclic aromatic traces or specific halogenated compounds. Nobody outside a working manufacturer can appreciate the real cost and complexity of shaving those last parts per million, or how much pilot-scale re-engineering is required to tweak a synthetic protocol while keeping costs manageable for users at scale. We do not cut corners with recycled solvents or mixed-reaction feeds, and years handling real customer claims have taught us: later headaches always overshadow any early gain from lax process control.
Dimethylacrylshikonin touches a wide span of high-value industries, from university labs screening for bioactivity, to industrial formulators who create visible pigments from active compounds. Its popularity comes partly from its backbone structure: the naphthoquinone ring remains iconic for biological and material science, and acryl side-groups open new doors in chemical modifications. Still, raw popularity means nothing if chemistry doesn’t back up the promise. No trader or catalog supplier spends a night with blown crystallization runs, or deals with a full powder dryer leaking noxious solvents at 3 AM because of an unexpected particle size shift. A manufacturer internalizes those lessons: every disaster turns into an addition to protocols, every costly rework changes how future batches gets run.
Customers researching new anti-microbials or antioxidants report that the tiniest contaminant or impurity profile shift can alter an entire study’s outcome. University scientists call for precise NMR or 2D-GC data, while industrial users drill down into the sources of batch-to-batch color variation. We keep logs of these interactions because they shape our process and quality management more than any outside consultant could recommend. Over time, the goal becomes chemical reliability, not just high purity for purity’s sake.
In our facility, raw material supply plays a decisive role. β,β-Dimethylacrylic intermediates must be sourced from stable partners who invest in controlled fermentation or robust chemical catalysis; any slips in up-front quality show up in months of product rework or quality failures. Sourcing high-grade shikonin from botanically controlled fields, not just commodity roots, prevents a tangled web of agrochemical residue problems. Since environmental scrutiny has intensified, we started up- and downstream monitoring for pesticides, sourcing from trusted partners rather than cash markets. Years of direct batch feedback pushed us to build strategic reserves of both raw materials and critical reagents, because weather patterns and border slowdowns have caught every chemical manufacturer at least once.
Moving dimethylacrylshikonin from bench scale to industrial lots always brings surprises. Once, minor humidity spikes in spring triggered unexpected clumping, which cascaded into downstream blending failures for a cosmeceuticals customer. With real skin in the game, we overhauled not just storage but packaging, investing in vapor-proof liners and climate-tracked warehousing. Getting to this solution took more than theory; losses in real time drove improvements. Another case: process bottlenecks appeared when only a single dryer model could handle the compound’s specific volatility profile, but production kept scaling. We learned to stagger batch timings, running extra quality spot-checks, and rarely accepted easy answers when faced with throughput-vs-consistency pressure.
End users in pharmaceutical development and pigment manufacturing each want a different balance of price, speed, and documentation. Some require full batch traceability, including access to archived NMR spectra or batch sheet histories. Others focus on color intensity or absorptivity at select wavelengths. We invested in a responsive quality management system that brings front-line results back to R&D regularly; every failed color test or purity dip becomes a chance to adjust procedures for practical gain.
Over the past four years, environmental regulations around processing solvents, energy use, and waste output tightened. We faced regulatory audits not just on paperwork compliance but on actual spend-down records from our emissions controls and on-site solvent recovery units. Tightening up waste treatment, investing in closed reactors, and switching to greener solvents didn’t come cheap, but these changes now define where the most resilient suppliers draw the line between short-term volume and long-term reliability.
One operational change came through direct talks with environmental technicians and frontline operators. Feedback pointed to pain points in handling spent mother liquors and fines that clogged waste streams after each crystallization. We worked with plant engineers to redesign filtration and solvent recycling, cutting hazardous discharge below legal limits and improving product recovery by nearly 12% per batch. These changes did not only reduce regulatory headaches but delivered measurable cost savings — and better outcomes for customers concerned about green chemistry and supply chain traceability. Those who visit our site now see not just sealed drums and label printers but robust waste handling and recovery infrastructure, which, more often than not, earns new business from customers seeking trusted, sustainable partners.
Clients approach us for more than just a quote. Sometimes they request help tuning an extraction protocol or ask for access to retained reference samples after months of storage. This type of relationship grows only with manufacturers willing to document, track, and analyze real usage feedback. We share both success stories and production failures, since transparency in manufacturing builds trust over repeat orders.
We learn as much from application failures as from easy wins. Once, a client noticed lower product color in a large batch of skin-care base and flagged the possibility of oxidation before blending. By comparing retained samples and batch storage history, we traced the cause back to minor packaging flaws. Tighter liner specs, shorter warehouse dwell times, and more robust quality checks became permanent features in our operating procedures.
Working with innovative university chemists also reshaped some process blocks. In one case, a research partner struggled with side reaction development due to trace inhibitors present in undistilled solvent. Test data gathered over weeks convinced us to overhaul upstream filtration and implement in-line solvent diagnostics, which in turn kept their downstream yields consistent. These types of cooperative troubleshooting efforts do not appear in glossy product brochures, but they add more value to repeat buyers than any marketing copy ever could.
Manufacturing Β,Β-Dimethylacrylshikonin today feels like standing at a crossroads of tradition and technology. Industry demand keeps growing, driven by sectors chasing natural product innovations, cleaner pigment alternatives, and pharmacology breakthroughs. To support that growth, we pour as much focus into process validation and feedback-driven development as we do into classical property testing. Our clients expect actionable data – not just COAs but impurity runs, storage safety studies, and forensic-level batch tracking. We have seen partnerships deepen as we focus on actual chemical outcomes, not just order volumes.
Future plans point toward continuous process upgrades, smarter automation, and ever-tighter environmental benchmarks. Software and real-time analytics drive decision-making as much as chemical intuition, speeding up feedback loops and reducing the risk of out-of-spec product escaping the site. Projects that once took months of scale-up now move to pilot in half the time, because we run parallel feedback from analytics, QA, and pilot clients in real time. For many customers, technical support now extends beyond email response and covers training, troubleshooting, and custom batch development.
The greatest reward in chemical manufacturing lies in seeing tangible, positive results delivered to those who rely on our efforts. Whether a new pigment blend holds up over a shelf-life trial, or a research lab hits a breakthrough by using a cleaner, more precisely characterized batch, our investment in quality always pays forward. That is the measure of success for Β,Β-Dimethylacrylshikonin — not simply as a catalog chemical, but as a result of thousands of hours from operators, scientists, and application partners striving for better outcomes in chemistry, industry, and real-world use.